SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing attention as the community rallies around its strategic expansion to the Stellar blockchain, viewing the integration as a major step toward real-world adoption and institutional payroll utility. Investors are actively debating the potential for further high-profile partnerships, such as with Ripple, while focusing on long-term accumulation and staking strategies despite broader market volatility.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz among traders due to its low circulating supply and small market cap, fueling speculation about its potential for outsized growth. The community is actively discussing the token's scarcity compared to Bitcoin and anticipating that increased volume could spark a major upward breakout.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is currently trending as investors focus on the company's recent FDA acceptance of a resubmission for its melanoma treatment, RP1, following an earlier complete response letter. Community discussion is polarized between optimism over the drug's clinical potential in high-need populations and skepticism regarding the likelihood of approval given the FDA's historical rejection and complex regulatory requirements.

Maul Coin

Maul Coin is trending as the community rallies around its active developer and pushes to build a long-term project while combatting market volatility from profit-takers. Supporters are actively using social media raids and promotional campaigns to drive organic growth and secure a higher market cap before a potential breakout.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased bullish sentiment and technical momentum as investors look toward upcoming earnings and potential growth in its automotive software division, QNX. The community is actively debating the stock's long-term valuation and future revenue guidance, with many expressing high conviction in the company's strategic shift toward cybersecurity and software-defined vehicle infrastructure.

Sound Group, Inc. is a global, AI-powered audio company on a mission to help people connect better and live happier. Leveraging its voice AI technologies and deep expertise in audio interaction, Sound Group is building a diverse ecosystem of intelligent audio products that cater to a global user base. By integrating technology, innovative products, and real-world data within a user-centric ecosystem, Sound Group generates a powerful growth flywheel that is driving continuous innovation and accelerating global expansion. The company was founded by Jinnan Lai and Ning Ding in 2010 and is headquartered in Singapore.

Sound Group Inc - ADR

Sound Group Inc

Sound Group Inc is trending as investors debate the sustainability of its recent growth, profitability, and special dividend payouts against the backdrop of its micro-cap valuation. While some community members highlight strong H2 2025 financial performance, low accounts receivable, and AI-driven expansion as signs of a legitimate turnaround, skeptics continue to voice concerns regarding the stock's volatility, potential manipulation, and the risks associated with its status as an unaudited foreign ADR.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toast Inc. is facing persistent downward pressure as investors weigh strong market share gains and platform stickiness against a broader tech sector sell-off and ongoing concerns regarding stock-based compensation. While the community remains divided between long-term supporters citing the platform's ubiquity and short-term traders frustrated by consistent price weakness, the stock continues to be a focal point for debate over whether current valuation levels represent a compelling buying opportunity.

Investment Managers Series Trust II - Tradr 2X Long IREN Daily ETF

Tradr 2X Long IREN Daily ETF

The IREX ETF is actively capturing trader attention as a volatile, leveraged play on IREN, with the community intensely debating whether to use it for short-term swing trading or long-term accumulation despite concerns over decay. Investors are focused on playing the price gaps and momentum of the underlying asset, often leveraging technical patterns like double bottoms or head-and-shoulders formations to navigate the instrument's high-risk, high-reward nature.

Maplebear, Inc. engages in the design and development of an online application that offers grocery delivery and pick-up services. The firm offers Instacart which enables users to connect with personal shoppers in the area who pick up and deliver groceries from local stores. The company was founded by Apoorva Mehta, Brandon Leonardo, and Max Mullen in 2012 and is headquartered in San Francisco, CA.

Maplebear Inc.

Instacart

Instacart is generating significant market buzz following a leadership transition and a boosted share repurchase program, with investors closely watching its competitive positioning against other major delivery platforms. The community remains divided between long-term bullish sentiment regarding the company's profitability and ad tech growth, and skepticism from traders wary of increasing competition from tech giants.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is trending as the community debates the broader impact of proposed government healthcare policies, including potential Medicare Advantage payment shifts and legislative debates over Affordable Care Act subsidies. Investors remain focused on the company's long-term profitability strategies, with active community discussion centered on navigating ongoing regulatory pressures and interpreting recent executive movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The OFS values the food company at about ₹10,000 crore.</li><li>IPO will open on October 29 and close on October 31, with listing slated for November 6.</li><li>The FMCG firm is known for brands like MTR, Rasoi Magic and Eastern</li></ul>&nbsp;Orkla India, formerly known as MTR Foods, is set to launch its ₹1,667-crore initial public offering (IPO) next week. The IPO will be open for subscription on October 29 and close on October 31.<h2 class="st-heading-2">IPO Details</h2>The company has set a price band of ₹695 - ₹730 per share. At the upper end of the price band, the company’s valuation is estimated at ₹10,000 crore. The IPO lot size comprises of 20 shares.The IPO is an entirely offer-for-sale (OFS), meaning no new shares will be issued and all proceeds will go to existing shareholders, including the promoter, Orkla Asia Pacific Pte Ltd, and minority shareholders Navas Meeran and Feroz Meeran.The issue has reserved 50% for qualified institutional buyers, 15% for non-institutional investors, and 35% for retail participants, with an additional 30,000 shares set aside for employees. The IPO allotment will be finalized on November 3, with shares credited on November 4, and the listing is tentatively scheduled for November 6 on the BSE and NSE.ICICI Securities, Citigroup Global Markets India, JP Morgan India, and Kotak Mahindra Capital Company are the book-running lead managers of the issue.Reports indicate that Orkla’s grey market premium is currently at ₹60.<h2 class="st-heading-2">Company Details</h2>Orkla India manufactures products such as masalas, ready-made meals, sweets, and breakfast mixes under leading brands like MTR, Eastern, and Rasoi Magic. Since FY19, the company has had a CAGR growth of 10.8%. The company has a strong presence in southern India.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

MTR Foods Parent Orkla India’s IPO Opens Next Week With ₹695-₹730 Price Band

IPO will open on October 29 and close on October 31, with listing slated for November 6

Equity

<ul class="summary-bullets"><li>India may permit higher imports of non-genetically modified U.S. corn and soymeal</li><li>Agreement may also include a framework for periodically reviewing tariffs and market access</li><li>US imposes fresh sanctions on Rosneft and Lukoil</li></ul>India and the United States are reportedly on the cusp of finalizing a long-overdue trade agreement. The deal could significantly lower U.S. tariffs on Indian goods from around 50% to around 15% to 16%, according to a report by Mint.The deal, centered on energy and agriculture, may also involve India gradually reducing its imports of Russian crude oil. Both the Indian Ministry of Commerce and the White House have yet to comment.U.S. President Donald Trump said he spoke with Prime Minister Narendra Modi on Tuesday, focusing mainly on trade and energy. Trump said that Modi assured him India would curb oil purchases from Russia. Modi confirmed the conversation via a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/narendramodi/status/1980826742379184347?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet">post</a> on X, thanking Trump for his Diwali greetings and emphasizing the shared values of democracy and unity against terrorism.As part of the proposed deal, India may permit higher imports of non-genetically modified U.S. corn and soymeal. The agreement could also include a framework for periodically reviewing tariffs and market access. An official announcement is expected at the upcoming ASEAN Summit later this month.Oil has been the focal point in the trade talks between the two countries. The United States had imposed a 50% tariff on Indian goods after Donald Trump accused New Delhi of funding the “senseless” war between Russia and Ukraine by purchasing the deeply discounted Russian crude oil.Last week, Trump said that Modi promised him that India would reduce imports, even as Indian officials denied it.<h2 class="st-heading-2">US Sanctions Russian Oil Companies</h2>Washington imposed fresh sanctions on Russia’s two largest oil companies, Rosneft and Lukoil, accusing Moscow of showing no real intent to end the war in Ukraine. The move came as Russia held a major nuclear training exercise and just a day after a planned summit between U.S. President Donald Trump and Russian President Vladimir Putin was abruptly cancelled. Trump said he called off the meeting because “it didn’t feel right.”The U.S. Treasury said the sanctions aim to weaken Moscow’s ability to finance its war efforts, marking a tougher stance after weeks of hesitation. Treasury Secretary Scott Bessent urged for an “immediate ceasefire,” with oil prices rising over $2 a barrel following the announcement.Trump, who had previously resisted energy sanctions in hopes that Putin would negotiate peace, said the lack of progress left him no choice. Ahead of a meeting with Chinese President Xi Jinping, Trump urged Beijing to use its influence on Moscow. Meanwhile, the European Union approved its 19th sanctions package, including a ban on Russian LNG imports.Despite the setback, Russian officials said summit preparations were still underway, though no date has been finalized. The delay follows renewed Russian demands for Ukraine to cede control of the Donbas region.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet in the Oval Office at the White House on February 13, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

New India-US Trade Deal Could Lower Tariffs To 15-16%: Report

India may permit higher imports of non-genetically modified U.S. corn and soymeal

Shares of Canara HSBC Life Insurance Company&nbsp;made a muted debut on the primary exchanges on Friday, listing at ₹106 per share, the same as its issue price.The shares gained slightly in half an hour of trading. At the time of writing, the stock’s price was ₹108.78 on the NSE and ₹108.85 on the BSE.&nbsp;Mixed Response To IPOThe issue was subscribed 2.3 times overall, led by strong institutional participation, with the QIB category subscribed 7.05 times, while retail and NII portions saw lower demand at 0.42 and 0.33 times, respectively.The ₹2,517.5-crore book-built offer was entirely an offer-for-sale (OFS) of 23.75 crore shares by promoters Canara Bank, HSBC Insurance (Asia-Pacific) Holdings, and Punjab National Bank. Post-listing, promoter holding has reduced from 77% to 62%.Before the IPO, the company raised ₹750.32 crore from anchor investors, including ICICI Prudential Mutual Fund, DSP MF, WhiteOak Capital, Mirae Asset MF, HDFC MF, Amundi Funds, Matthews India Fund, Tata MF, Motilal Oswal MF, Allianz Global Investors Fund and Societe Generale.The IPO, open from October 10 to 14, had a price band of ₹100 - ₹106 per share, with a minimum retail lot size of 140 shares.SBI Capital Markets, BNP Paribas, HSBC Securities, JM Financial, and Motilal Oswal acted as lead managers for the issue.On Thursday, Canara Robeco Asset Management Company (AMC) made a <a href="https://stocktwits.com/news-articles/markets/equity/canara-robeco-amc-lists-at-5-premium-stock-climbs-above-300-on-debut/ch6YrusR3V1">lukewarm debut</a> on the primary indices, listing at a 5.4% premium.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Artistic representation of a trending chart.

Canara HSBC Life Insurance Company Makes Dull Market Debut; Lists At Issue Price

The stock gained marginally within half an hour after listing

Canara Robeco Asset Management Company (AMC) made a lukewarm debut on the primary indices on Thursday, listing at a 5.4% premium.Shares of the AMC opened at ₹280.25 on both the NSE and the BSE, representing a 5.36% gain over its IPO price of ₹266 per share.However, the stock quickly rose above ₹300. At the time of writing, the stock was trading at ₹306 on the NSE and ₹306.7 on the BSE.IPO Receives Decent Investor InterestCanara Robeco AMC’s initial public offering (IPO) garnered reasonable investor interest over its three-day subscription period, from October 9 to October 13. It was subscribed nearly 10 times, with the retail category recording a subscription of 1.91 times, QIBs were oversubscribed 25.92 times, and non-institutional investors (NIIs) saw 6.45x subscription.The shares were offered at a price band of ₹253 - ₹266 per share, with the total IPO size at ₹1,326 crore, comprising only an offer for sale (OFS) of around five crore shares, and no fresh issue component.In the OFS, Canara Bank sold 2,59,24,266 shares while Orix Corporation offloaded 2,39,30,091 shares.The proceeds from the IPO will go to the selling promoters, with Canara Bank holding 51% and Orix Corporation holding the remaining stake in the AMC.Ahead of the public subscription, the company raised over ₹750 crore from anchor investors, which included prominent institutional participants such as ICICI Prudential MF, HDFC MF, DSP MF, WhiteOak Capital, Mirae Asset MF, Allianz Global Investors, Amundi Funds, Matthews India Fund, Tata MF, Motilal Oswal MF, and Societe Generale.The IPO was managed by SBI Capital Markets, Axis Capital, and JM Financial as book-running lead managers, with MUFG Intime India serving as the registrar.Brokerage Says Canara Bank’s Distribution Network To Benefit The AMCPL Capital initiated coverage on Canara Robeco Asset Management Company with a 'Buy' rating. The brokerage set a target price of ₹320, implying over 20% upside from the IPO price of ₹266, citing strong core earnings potential, higher equity share, and distribution advantages from its parent, Canara Bank.Company DetailsCanara Robeco AMC was established in 1993 and is among India’s oldest asset management firms. It acts as the investment manager for Canara Robeco Mutual Fund. Headquartered in Mumbai, the company is a joint venture between Canara Bank and Orix Corporation Europe N.V. (formerly Robeco Group N.V.).For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Close up of female hand touching stock market analysis digital display screen TradingView chart, analyzing investment and financial trading data in candlestick chart on a touch screen interface.

Canara Robeco AMC Lists At 5% Premium; Stock Climbs Above ₹300 On Debut

The stock opened at ₹280 but rose to above ₹300 in half an hour of trading

Rubicon Research made a strong debut on the primary indices on Thursday, listing at a 28% premium.Shares of the pharmaceutical company opened at ₹620 on the NSE, representing a 27.84% gain over its IPO price of ₹485 per share. It debuted at ₹620.10 on the BSE, up 27.86%.At the time of writing, the stock was trading at ₹600.55 on the NSE and ₹601.1&nbsp;on the BSE.Overwhelming Investor ResponseThe pharmaceutical company launched its ₹1,377.5-crore IPO for subscription between October 9 and October 13, witnessing robust participation across investor categories.The issue was subscribed 104 times overall, with non-institutional investors (NIIs) bidding 97.61 times, qualified institutional buyers (QIBs) 130.26 times, and retail investors 35.47 times. The IPO was priced between ₹461 and ₹485 per share with a lot size of 30 shares.The IPO comprised a fresh issue of ₹500 crore and an offer for sale (OFS) of ₹877.5 crore by General Atlantic Singapore&nbsp;RR, whose holding will decline to around 35% post-listing.The issue received strong anchor backing of ₹619 crore from global and domestic investors, including Goldman Sachs, HDFC Mutual Fund, Fidelity Funds, ICICI Prudential MF, Kotak Mahindra MF, Amansa Holdings, and Aranda Investments.Proceeds of about ₹310 crore from the fresh issue will be utilized for debt repayment, inorganic growth, and general corporate purposes.The offering is being managed by JM Financial, Axis Capital, IIFL Capital, and SBI Capital Markets, with MUFG Intime India serving as the registrar.Brokerages Bullish But Flag Reliance On US MarketJM Financial: Rubicon Research stands out for its leadership in high-value U.S. generic and specialty pharmaceutical markets, backed by integrated R&amp;D, manufacturing, and regulatory strengths. The acquisition of U.S.-based Validus has enhanced its margins, efficiency, and direct access to prescribers, while a strong product pipeline and steady FDA approvals reinforce its growth outlook.However, the stock’s high valuation of around 60× FY25 earnings reflects ambitious growth assumptions. With over 98% of revenue coming from the U.S., the company faces market concentration, regulatory, and currency risks, along with the ongoing need for heavy R&amp;D investment.Still, Rubicon’s evolution from an Indian contract developer to a global specialty exporter positions it as one of the most agile mid-cap pharma stories of 2025, it said.ICICI Direct: Rubicon reported a revenue CAGR of 80% between FY23 and FY25, driven by rising market share and the launch of new products. The company achieved healthy operating performance with EBITDA margins of 19.9% and a return on capital employed (RoCE) of 26% in FY25.Despite these strong financials, the IPO’s valuation, 59 times P/E and 32 times EV/EBITDA at the upper price band, appears expensive given the company’s heavy reliance on U.S. revenues and related compliance risks.Company DetailsFounded in 1999, Rubicon Research is a pharmaceutical company specializing in the development, manufacturing, and commercialization of differentiated formulations. As of June 2025, the company had 72 ANDA and NDA approvals from the US FDA, with 66 already commercialized. It also has 17 new products awaiting approval and 63 under development, serving 96 customers, including the top three US wholesalers.Beyond the US, Rubicon holds 48 product registrations across Australia, the UK, Singapore, Saudi Arabia, and the UAE, with plans to begin operations once approvals are received. The company also provides contract manufacturing services in Australia and New Zealand.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Rubicon Research Lists At 28% Premium After Blockbuster IPO Subscription

The stock, which received 104x bids over the shares offered, listed at ₹620 on the NSE

Wholesale inflation in India eased to 0.13% in September, compared to 0.52% last month. According to an official press release by the government, the positive inflation rate was primarily driven by rising prices in manufactured food products, other manufactured goods, non-food items, textiles, and transport equipment.WPI Food Index inflation was negative, at -1.99% in September, compared to 0.21% in August.Inflation BreakdownThe wholesale inflation for the Primary Articles category came in at -3.32% in September, from -2.10% in the previous month.&nbsp;Within this, food articles inflation (-5.22%), including pulses, cereals and vegetables, eased compared to the previous month. Non-food articles prices also fell to 3.14% from 5.56% in August. In contrast, the price of fuel and power edged slightly higher to -2.58% from -3.17%.And in the manufactured products category, inflation was 2.33% compared to 2.55% in August.Retail Inflation Falls To 8-year LowsIndia’s annual <a href="https://stocktwits.com/news-articles/markets/equity/india-s-retail-inflation-falls-to-over-8-year-lows-in-september/ch6Sh7wR3ke">retail inflation</a> fell to 1.54% in September from 2.07 % in August, and marked the lowest year-on-year inflation since June 2017. A drop in food inflation boosted it.Earlier this month, the Reserve Bank of India (RBI) revised the FY26 CPI inflation forecast lower to 2.6% from 3.1%. The central bank cited the impact of the GST reform and a more-than-expected decline in food prices as the primary reasons for the revision.Analysts at JM Financial expect inflation to average below 2.5% in FY26, opening up the room for rate cuts by the RBI in its December policy.&nbsp;The next MPC meeting for 2025 is scheduled for December 3-5.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

India’s Wholesale Inflation Eases To 0.13% in September

India’s inflation trends show easing price pressures, raising the expectations for a potential RBI rate cut in December.

Pharmaceutical company Rubicon Research saw strong investor participation for its initial public offering.On the final day of subscription, the IPO was subscribed a staggering 93.94 times, according to BSE data. The issue received bids for 154.59 crore shares against an offer of 1.65 crore shares. Retail investors applied 30.39 times the shares of offer, non-institutional investors 93.72 times, and Qualified Institutional Buyers (QIBs) 115.62 times.The ₹1,377.5-crore IPO comprises a fresh equity issue of ₹500 crore and an Offer For Sale (OFS) of ₹877.5 crore by promoter General Atlantic Singapore RR Pte Ltd, whose stake is expected to fall to over 35% post-IPO.Rubicon Research IPO has a price band between ₹461 to ₹485 per share.Proceeds from the fresh issue, around ₹310 crore, will be used for debt repayment and strategic initiatives, including acquisitions and general corporate purposes. Anchor investors, including Kotak Mutual Fund and Motilal Mutual Fund, have committed around ₹169 crore.GMP Indicates Firm ListingAccording to reports, the company's shares are available at a substantial premium of ₹110 in the grey market on Monday.Analyst Verdict: ApplyRubicon’s strengths include a strong portfolio with over 25% market share in seven US products, advanced R&amp;D centres in India and Canada, and a well-established US distribution network, said SEBI-registered <a href="https://stocktwits.com/MBA_INVESTMENTWALA">analyst Aditya Hujband</a>.<stembedurl>https://stocktwits.com/MBA_INVESTMENTWALA/message/632022484</stembedurl>However, risks include heavy reliance on the US market, regulatory uncertainties, competitive pressures, and foreign exchange volatility, he added.Overall, the IPO appears promising for long-term investors, and Hujband recommends applying for it.Company DetailsFounded in 1999, Rubicon Research is a pharmaceutical company specializing in the development, manufacturing, and commercialization of differentiated formulations. As of June 2025, the company had 72 ANDA and NDA approvals from the US FDA, with 66 already commercialized. It also has 17 new products awaiting approval and 63 under development, serving 96 customers, including the top three US wholesalers.Beyond the US, Rubicon holds 48 product registrations across Australia, the UK, Singapore, Saudi Arabia, and the UAE, with plans to begin operations once approvals are received. The company also provides contract manufacturing services in Australia and New Zealand.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rubicon Research Sees Overwhelming Response On Final Day Of IPO

The grey market premium stands at ₹110, indicating a strong market debut

India’s services sector maintained a healthy growth in September, supported by strong demand, rising new orders, and favorable business conditions, even as it softened compared to August.The HSBC India Services PMI Business Activity Index stood at 60.9 in September, well above the neutral 50.0, but slightly below August’s 62.9, indicating a modest easing in momentum.Exports continued to rise but at the slowest pace since March, as competition from lower-priced international services weighed on order growth. Employment growth also moderated, with less than 5% of companies reporting hiring growth, while outstanding business volumes increased at a marginal pace, reflecting limited pressure on capacity.At the end of Q2, Indian services firms saw a continued rise in expenses, with labour and material costs increasing since August. Prices charged for services increased modestly, marking the slowest rate since March and aligning with long-term averages.Despite these softer trends, business sentiment strengthened, reaching a six-month high. Companies cited advertising, efficiency gains, competitive pricing, and tax incentives as key drivers supporting optimism for the year ahead.“Business activity in India’s services sector eased in September from the recent high August level. Most trackers moderated but nothing in the survey suggested there is a big loss in growth momentum in services. Instead, the Future Activity Index rose to its highest level since March, indicating strengthening optimism services companies about business prospects,” said Pranjul Bhandari, Chief India Economist at HSBC.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian rupee cash bills and stock market indicator board. | Image source: Getty Images

India’s Service Sector Output Eases In September, But Optimism Hits Six-Month High

Companies cited advertising, efficiency gains, competitive pricing, and tax incentives as key drivers supporting optimism for the year ahead.

GK Energy made a strong debut in a weak market on Friday, with shares listing at a 12% premium on the NSE.Shares of the company opened at ₹171 on the NSE, compared to the issue price of ₹153. On the BSE, the stock listed at ₹165.20, marking an 8% premium.Ahead of listing, the company’s unlisted shares were trading at a grey market premium (GMP) of around 12%.At the time of writing, GK Energy was trading at ₹170 on the NSE and ₹170.2 on the BSE.IPO DetailsThe ₹464.26 crore initial public offering, with a price band of ₹145 - ₹153 per share, comprised a fresh issue of equity shares worth ₹400 crore and an offer-for-sale of ₹64.26 crore.The issue garnered an impressive response,&nbsp;with subscriptions reaching approximately 89.62 times the original number. Bids reached 1,987,778,982 shares compared to just 22,180,828 shares available for offer.The portion allocated to qualified institutional buyers (QIBs) was oversubscribed by 186.29 times, while non-institutional investors (NIIs) oversubscribed by 122.73 times. The segment for retail investors was oversubscribed by 20.79 times.Allocation was structured with 50% for qualified institutional buyers (QIBs), 15% for non-institutional bidders, and 35% for retail individual investors.The IPO allowed a minimum investment of 98 shares per lot, amounting to ₹14,994 at the upper price band.IIFL Capital Services and HDFC Bank managed the IPO.Company DetailsGK Energy offers engineering, procurement and commissioning (EPC) services for solar-powered agricultural water pump systems. It provides farmers with an end-to-end solution for survey, supply, assembly, installation, testing, commissioning, and maintenance of solar-powered pump systems.Before the IPO, the company raised ₹139.27 crore from anchor investors, including HSBC Mutual Fund, Motilal Oswal MF, Bandhan MF, Citigroup Global Markets Mauritius, Pinebridge Global Funds, and Société Générale, among others.For updates and corrections, email newsroom[at]stocktwits[dot]com.

GK Energy Shares Surge On Debut Even As Broader Indian Markets Struggle

Shares opened at ₹171 on the NSE, and ₹165.20 on the BSE, compared to the issue price of ₹153

Saatvik Green Energy made a soft debut on Friday, listing at a 1% discount on the BSE with an opening price of ₹460 against its issue price of ₹465. Meanwhile, on the NSE, the stock is listed at par.Ahead of the listing, Saatvik Green Energy shares were trading at a premium of ₹10 in the grey market. At the time of writing, the stock was trading at ₹450&nbsp;on the NSE and ₹450.85 on the BSE.IPO DetailsThe IPO, worth ₹900 crore, had received decent investor interest, being subscribed 6.57 times during its three-day bidding window from September 19 to 23. The price band was fixed at ₹442-₹465 per share, with a minimum lot size of 32 shares.The IPO consisted of a fresh issue of 1.51 crore shares, amounting to ₹700 crore, and an offer for sale of 0.43 crore shares, totaling to ₹200 crore.Saatvik Green Energy plans to utilise ₹177 crore of the net fresh issue proceeds for repayment of certain borrowings. ₹477 crore has been earmarked to establish a 4 GW solar PV module manufacturing facility at Ganjam, Odisha, through its subsidiary, Saatvik Solar Industries. The remaining funds will be allocated to general corporate purposes.DAM Capital Advisors, Ambit, and Motilal Oswal acted as merchant bankers, while Kfin Technologies served as registrar to the issue.Ahead of the IPO, the company raised ₹269.4 crore through its anchor book, which saw participation from leading domestic institutions, including HDFC Mutual Fund, Nippon Life India, Bandhan MF, SBI General Insurance, and 360 ONE.Company DetailsSaatvik Green Energy is one of India’s leading solar PV module manufacturers, with an existing operational capacity of approximately 3.8 GW.It also offers engineering, procurement, and construction (EPC) services along with operations and maintenance (O&amp;M) solutions.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

 Rows of photovoltaic modules in an Iberdrola solar park in Germany at its official commissioning.

Saatvik Green Energy Shares Make Weak Debut In Indian Markets 

The stock debuted at ₹460 on the BSE, 1% below its issue price of ₹465, and listed at par on the NSE.

NIFTYSMLCAP100.NSE
NIFTY SmallCap 100

Feed

News

Sentiment

Fundamentals

Info

Latest NIFTYSMLCAP100.NSE News

NIFTYSMLCAP100.NSENIFTY SmallCap 100